Link to this page
PMO Precision Medicine Ontology
Last uploaded:
December 16, 2020
Jump to:
| Preferred Name | Bosutinib | |
| Synonyms |
|
|
| ID |
http://www.phoc.org.cn/pmo/class/PMO_00026223 |
|
| Database_Cross_Reference |
NCI_FDA:5018V4AEZ0 SNOMEDCT_US:703128001 NDDF:014636 MSH:C471992 MEDCIN:343287 MMSL:28803 USPMG:MTHU002517 MMSL:d07901 MTHSPL:5018V4AEZ0 PDQ:CDR0000467222 RXNORM:1307619 SNOMEDCT_US:703586005 VANDF:4031718 DRUGBANK:DB06616 NCI:C60809 ATC:L01XE14 NDFRT:N0000185728
|
|
| label |
Bosutinib
|
|
| MCID |
MC00601796
|
|
| PMOID |
PMO:00026223
|
|
| prefixIRI |
pmo:PMO_00026223
|
|
| prefLabel |
Bosutinib
|
|
| Synonym |
bosutinib chemotherapeutics bosutinib Bosutinib (product) 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile bosutinib (medication) 4-Anilinobenzo(g)quinoline-3-carbonitrile BOSUTINIB 4-Anilino-3-quinolinecarbonitrile Bosutinib (substance)
|
|
| Tree Number |
T6.4.4.1.2.27.13
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping